Curative Biotechnology (CUBT) Short Interest Ratio & Short Volume

Short interest is the volume of Curative Biotechnology shares that have been sold short but have not yet been closed out or covered. As of March 15th, investors have sold 23,100 shares of CUBT short. 0.00% of Curative Biotechnology's shares are currently sold short. Learn More on Curative Biotechnology's current short interest.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.00% of Curative Biotechnology's floating shares are currently sold short.

Curative Biotechnology saw a increase in short interest in March. As of March 15th, there was short interest totaling 23,100 shares, an increase of ∞ from the previous total of 0 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

0.00% of Curative Biotechnology's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Curative Biotechnology: BioRestorative Therapies, Inc. (6.07%), Mangoceuticals, Inc. (7.08%), Pacific Health Care Organization, Inc. (0.01%), Ontrak, Inc. (1.78%), NewGenIvf Group Limited (20.42%), Fresenius Medical Care AG (0.14%), DaVita Inc. (5.82%), Sotera Health (7.40%), agilon health, inc. (6.05%), Progyny, Inc. (9.04%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($26.28 billion), iShares 20+ Year Treasury Bond ETF ($9.53 billion), Strategy Incorporated ($8.50 billion), Apollo Global Management, Inc. ($4.86 billion), Super Micro Computer, Inc. ($4.85 billion), Charter Communications, Inc. ($4.28 billion), Capital One Financial Co. ($4.08 billion), AppLovin Co. ($3.82 billion), Canadian Natural Resources Limited ($3.78 billion), and Schlumberger Limited ($2.87 billion). View all of the most shorted stocks.

Short selling CUBT is an investing strategy that aims to generate trading profit from Curative Biotechnology as its price is falling. CUBT shares are trading up $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Curative Biotechnology occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CUBT, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CUBT, twice per month. The most recent reporting period available is March, 15 2025.